Clinical Trial Update: Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for KHK2375 in advanced or recurrent breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KHK2375

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Advanced or Recurrent Breast Cancer | Phase 2 | Status: COMPLETED